NEUROMOD UCon: Pilot Study of Dorsal Genital Nerve Stimulation for Management of Bladder Overactivity Following Spinal Cord Injury

Status: Active_not_recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Following spinal cord injury signals between the brain and the bladder are disrupted. As a result the bladder often becomes overactive which can lead to the need for frequent trips to the toilet, regular incontinence episodes and a decreased quality-of-life. Neuromodulation is a therapy that aims to target the nerves that become overactive controlling the bladder, stopping the bladder overactivity on demand using an external (non-invasive) nerve stimulation box and sticker electrodes placed on the penis or clitoris. This study is a pilot study that aims to investigate neuromodulation for improving symptoms of bladder overactivity when used by 10 people over eight weeks at home. We will assess whether using the device improves bladder capacity, incontinence, frequency of needing the toilet and whether there are any longer lasting changes after 8 weeks. Finally, the study will aim to find out the acceptability of using this type of therapy for participants and the acceptability of the device we are using. Participants in this trial will participate over 13 weeks and need to visit our centre in Stanmore to have urodynamics tests in the 1st, 9th and 13th week. At home they will use a small stimulation device on a daily basis for 8 weeks to control overactivity in the bladder. Whilst at home they will record relevant outcomes in several three-day diaries and questionnaires. They will record baseline data before starting stimulation and for 4 weeks after.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Spinal Cord Injury (suprasacral, AIS A-D);

• \>18 years old, no upper age limit;

• SCI sustained \>6 months ago;

• NDO;

• Capable of using the device at home either independently or with existing support.

• Male or female

• Willing and able to provide informed consent

Locations
Other Locations
United Kingdom
Royal National Orthopaedic Hospital
Stanmore
Time Frame
Start Date: 2023-01-23
Completion Date: 2024-05-26
Participants
Target number of participants: 10
Treatments
Experimental: Treatment
Related Therapeutic Areas
Sponsors
Leads: University College, London
Collaborators: Royal National Orthopaedic Hospital NHS Trust

This content was sourced from clinicaltrials.gov